Stephen J. Tapscott

Active 1979–2025

126
Papers
27,000
Citations
92
h-index
122
i10-index

Citations

Citations per year for Stephen J. Tapscott1931: 1 citations1970: 1 citations1972: 1 citations1980: 4 citations1981: 17 citations1982: 25 citations1983: 38 citations1984: 25 citations1985: 22 citations1986: 22 citations1987: 21 citations1988: 11 citations1989: 52 citations1990: 115 citations1991: 142 citations1992: 200 citations1993: 184 citations1994: 181 citations1995: 145 citations1996: 131 citations1997: 117 citations1998: 116 citations1999: 145 citations2000: 190 citations2001: 136 citations2002: 172 citations2003: 142 citations2004: 164 citations2005: 218 citations2006: 275 citations2007: 207 citations2008: 248 citations2009: 238 citations2010: 276 citations2011: 294 citations2012: 298 citations2013: 303 citations2014: 258 citations2015: 204 citations2016: 218 citations2017: 220 citations2018: 174 citations2019: 632 citations2020: 741 citations2021: 704 citations2022: 426 citations2023: 366 citations2024: 483 citations2025: 180 citations2026: 5 citations1932–1969: no citations, so these years are not shown1971: no citations, so this year is not shown1973–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,157 citing papers, 38.8% of this breakdownUnited Kingdom: 586 citing papers, 7.2% of this breakdownChina: 534 citing papers, 6.6% of this breakdownGermany: 463 citing papers, 5.7% of this breakdownFrance: 415 citing papers, 5.1% of this breakdownCanada: 356 citing papers, 4.4% of this breakdownItaly: 348 citing papers, 4.3% of this breakdownJapan: 344 citing papers, 4.2% of this breakdownNetherlands: 207 citing papers, 2.5% of this breakdownAustralia: 168 citing papers, 2.1% of this breakdownSpain: 136 citing papers, 1.7% of this breakdownSwitzerland: 125 citing papers, 1.5% of this breakdown
0%38.8%Other 15.9%

Fields

  • Biochemistry, Genetics and Molecular Biology71.7%
  • Medicine14.4%
  • Neuroscience8.1%
  • Agricultural and Biological Sciences2.3%
  • Immunology and Microbiology1.5%
  • Environmental Science0.5%
  • Other1.5%

Topics

  • Muscle Physiology and Disorders8.9%
  • RNA Research and Splicing4.9%
  • Genomics and Chromatin Dynamics3.8%
  • Epigenetics and DNA Methylation3.2%
  • RNA modifications and cancer3.1%
  • Pluripotent Stem Cells Research2.6%
  • Other73.5%

Coauthors

All papers

Open in search
  1. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons

    Authors: , , , , , , , , , , , , , , - Nature Genetics 2017 cited by 779

  2. A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy

    Authors: , , , , , , , , , , , , , , - Science 2010 cited by 794

  3. Conservation and innovation in the DUX4-family gene network

    Authors: , , , , - Nature Genetics 2017 cited by 356

  4. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2012 cited by 664

  5. Unchecked oxidative stress in skeletal muscle prevents outgrowth of disseminated tumour cells

    Authors: , , , , , , , , , , - Nature Cell Biology 2022 cited by 57

  6. Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2016 cited by 272

  7. DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy

    Authors: , , , , , , , , , , - Developmental Cell 2011 cited by 475

  8. Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene

    Authors: , , , , , , , , , , - PLoS Genetics 2010 cited by 494

  9. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle

    Authors: , , , , , , - Human Molecular Genetics 2014 cited by 226

  10. MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD

    Authors: , , , , , , , , , , , , , - Human Molecular Genetics 2018 cited by 135

  11. DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade

    Authors: , , , , , , - Developmental Cell 2019 cited by 127

  12. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1989 cited by 1,005

  13. Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies

    Authors: , , , , , , , , , , , - Human Molecular Genetics 2020 cited by 83

  14. The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage

    Authors: , , , , , , , , , , , - Science 1991 cited by 1,590

  15. MyoD and the transcriptional control of myogenesis

    Authors: , - Seminars in Cell and Developmental Biology 2005 cited by 860

  16. Facioscapulohumeral muscular dystrophy: the road to targeted therapies

    Authors: , , , , , , , - Nature Reviews Neurology 2023 cited by 65

  17. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription

    Authors: - Development 2005 cited by 766

  18. DUX4 Binding to Retroelements Creates Promoters That Are Active in FSHD Muscle and Testis

    Authors: , , , , , , , , , - PLoS Genetics 2013 cited by 167

  19. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2

    Authors: , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2014 cited by 166

  20. Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy

    Authors: , , , , , , , , , - BMC Musculoskeletal Disorders 2021 cited by 49

  21. Genome-wide MyoD Binding in Skeletal Muscle Cells: A Potential for Broad Cellular Reprogramming

    Authors: , , , , , , , , , , , - Developmental Cell 2010 cited by 492

  22. The FSHD2 Gene SMCHD1 Is a Modifier of Disease Severity in Families Affected by FSHD1

    Authors: , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2013 cited by 189

  23. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy

    Authors: , , , , , , , , , - Journal of Pharmacology and Experimental Therapeutics 2019 cited by 89

  24. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence

    Authors: , , - Trends in Molecular Medicine 2011 cited by 144